Bone-Conduction Systems (BAHS) & Active Middle Ear Implants

Bone-Conduction Systems & Active Middle Ear Implants

When structural anomalies, chronic infectious pathology, or severe conductive blocks render conventional air-conduction amplification ineffective or medically contraindicated, implantable auditory devices provide a vital alternative. Understanding the mechanical biophysics, surgical coupling interfaces, audiometric candidacy criteria, and post-operative management of Bone-Anchored Hearing Systems (BAHS) and Active Middle Ear Implants (AMEI) is a cornerstone of doctoral-level audiological practice.

---

Biophysics of Direct Bone Conduction

Bone conduction sound transmission occurs through three distinct, concurrently operating biomechanical mechanisms:

1. Inertial Bone Conduction (Ossicular Inertia): Vibrational energy applied to the skull causes the temporal bone to oscillate. Because the ossicular chain is suspended elastically within the middle ear cavity, its inertia causes it to lag behind the accelerating cranial bone. This relative motion drives the stapes footplate in and out of the oval window, generating fluid traveling waves within the cochlea. This mechanism dominates low-to-mid frequency perception ($<1000\,\text{Hz}$).
2. Compressional / Distortional Bone Conduction: At higher frequencies ($>1500\,\text{Hz}$), the skull vibrates in complex segmental modes. These compressional waves directly deform the petrous pyramid and otic capsule. Because the fluid in the scala vestibuli and scala tympani is virtually incompressible, and because the round window membrane is roughly twenty times more compliant than the stapes footplate, compressional deformation forces fluid displacement toward the round window, displacing the basilar membrane.
3. Osseotympanic Bone Conduction: Vibrations of the bony and cartilaginous walls of the external auditory canal radiate acoustic sound pressure into the canal lumen. If the canal is unoccluded, this energy escapes into the environment. If the canal is occluded (or stenotic/atretic), this radiated acoustic pressure is forced onto the tympanic membrane, driving the ossicular chain via conventional air conduction pathways.

Conventional air-conduction hearing aids rely on an intact external auditory canal, a mobile tympanic membrane, and an intact ossicular chain. When severe middle ear pathology creates a massive air-bone gap (ABG), conventional hearing aids must generate substantial acoustic output to overcome the conductive barrier, often resulting in acoustic feedback, distortion, and canal occlusion complications. BAHS devices circumvent the outer and middle ear entirely, delivering mechanical vibrational energy directly to the temporal bone to stimulate the cochlea via inertial and compressional bone conduction.

---

Clinical Indications & Audiometric Candidacy

Clinical candidacy for BAHS falls into three primary diagnostic categories: conductive hearing loss, mixed hearing loss, and single-sided deafness (SSD).

1. Conductive Hearing Loss

• Audiometric Criteria: Normal or near-normal bone-conduction thresholds, defined as a bone-conduction pure-tone average (BC PTA at $500, 1000, 2000, 3000\,\text{Hz}$) $\le 20-25\,\text{dB HL}$, accompanied by a substantial air-bone gap (typically $\ge 30\,\text{dB HL}$).
• Clinical Etiologies:
  • Congenital aural atresia and severe microtia (e.g., in Treacher Collins syndrome, Goldenhar syndrome, or isolated developmental arrest) where the external auditory canal is absent or stenotic.
  • Chronic suppurative otitis media (CSOM) with persistent, draining mastoid cavities.
  • Post-canal wall down (CWD) mastoidectomy cavities with active or recurrent drainage.
  • Severe chronic otitis externa or eczema where occlusive earmolds trigger severe maceration and drainage.
  • Severe otosclerosis or tympanosclerosis where reconstructive middle ear surgery (stapedectomy) is medically contraindicated or refused.

2. Mixed Hearing Loss

• Audiometric Criteria: Sensorineural bone-conduction thresholds determine the necessary device power category, alongside a conductive air-bone gap of at least $10-15\,\text{dB}$ (and ideally $\ge 30\,\text{dB}$):
  • Standard-power processors: BC PTA $\le 45\,\text{dB HL}$.
  • Medium-to-high power processors: BC PTA $\le 55\,\text{dB HL}$.
  • Super-power processors: BC PTA up to $65\,\text{dB HL}$ (e.g., Oticon Medical Ponto 5 SuperPower).
• Clinical Rationale: By directly stimulating the sensorineural component without having to overcome the conductive air-bone gap, the processor operates with substantially less gain than a conventional hearing aid, minimizing saturation distortion and feedback.

3. Single-Sided Deafness (SSD)

• Audiometric Criteria: Severe-to-profound unilateral sensorineural hearing loss in the affected ear (PTA $\ge 90\,\text{dB HL}$, poor speech discrimination) with normal or near-normal hearing in the contralateral ear (contralateral air-conduction and bone-conduction PTA $\le 20-25\,\text{dB HL}$).
• Biophysical Mechanism: The BAHS sound processor is placed on the deaf side. It captures acoustic signals originating on the impaired side, converts them to mechanical vibrations, and transmits them transcranially across the skull to stimulate the contralateral, normal-hearing cochlea.
• Transcranial Attenuation: Cranial bone exhibits minimal interaural attenuation for bone conduction ($0-10\,\text{dB}$, compared to $40-70\,\text{dB}$ for air conduction). As a result, vibrational energy propagates across the calvarium with negligible power loss.
• Acoustic Benefits: Effectively eliminates the head shadow effect (which normally attenuates high-frequency speech sounds arriving at the deaf side by $6-12\,\text{dB}$). Patients experience marked improvements in speech understanding in background noise when speech originates from the impaired side.
• Critical Clinical Reality & Exam Trap: Transcranial bone conduction routing does not restore true binaural hearing. Because both acoustic inputs are ultimately processed by a single cochlea, patients do not gain true binaural squelch, binaural summation, or horizontal sound localization capabilities. Restoring true binaural hearing in SSD requires a cochlear implant in the deaf ear.

---

Coupling Modalities: Surgical vs. Non-Surgical Systems

Bone-conduction systems differ fundamentally in how vibrational force is transferred from the external sound processor to the underlying calvarium.

1. Pediatric Non-Surgical Systems (Softband & Adhesive Adapters)

• FDA Mandate: Titanium osseointegrated surgical implantation is FDA-cleared only for patients aged 5 years and older.
• Anatomical Rationale: The calvarium of infants and children under 5 years is thin ($<3-4\,\text{mm}$), pliable, and poorly mineralized, lacking a well-differentiated diploic space. Attempting to place an osseointegrated fixture carries extreme risks of intracranial dural penetration, subdural hematoma, cerebrospinal fluid (CSF) leakage, and high fixture extrusion rates.
• Coupling Mechanics: The external bone-conduction transducer is held firmly against the skin overlying the mastoid or squama using an elastic Softband, rigid steel headband, or specialized adhesive tape adapter.
• Acoustic Attenuation: Intervening cutaneous and subcutaneous fat layers dampen mechanical vibration, absorbing approximately $10-15\,\text{dB}$ of energy—primarily in the critical high frequencies ($>1000\,\text{Hz}$). Audiologists must apply compensatory high-frequency prescriptive gain during softband programming.

2. Percutaneous Titanium Abutment Systems (e.g., Baha Connect, Ponto)

• Surgical Mechanism: A titanium implant fixture ($3-4\,\text{mm}$ depth) is surgically drilled into the mastoid cortex. Through osseointegration (the direct structural and functional connection between living bone and the titanium surface, pioneered by Per-Ingvar Brånemark), the fixture locks permanently into the bone. A skin-penetrating titanium abutment extends through the scalp, providing a direct snap-coupling for the sound processor.
• Acoustic Superiority: Direct bone coupling provides 100% mechanical transmission efficiency with zero skin-damping attenuation. This maximizes high-frequency sound transfer up to $8000\,\text{Hz}$, providing optimal speech clarity and audibility of high-frequency consonants.
• Complications & Holgers Grading: Because the skin barrier is permanently breached, patients require meticulous lifelong hygiene. Complications include skin overgrowth, chronic crusting, fixture loss ($5-10\%$ failure rate), and soft-tissue infections.

3. Passive Transcutaneous Magnetic Systems (e.g., Baha Attract, Sophono)

• Surgical Mechanism: An internal magnetic plate is secured to an osseointegrated fixture beneath intact skin and periosteum. The external processor features a matching magnetic baseplate that adheres to the scalp through magnetic attraction.
• Clinical Advantage: Intact skin eliminates the daily hygiene burden, eliminates skin overgrowth, and prevents Holgers abutment infections.
• Clinical Drawbacks:
  • Cutaneous Damping: The intervening skin and subcutaneous tissue attenuate high-frequency mechanical vibration by $5-15\,\text{dB}$ above $1000\,\text{Hz}$, requiring more processor power.
  • Tissue Ischemia & Pressure Necrosis: Excessive magnetic strength causes localized soft-tissue ischemia, pain, erythema, and cutaneous necrosis. Conversely, insufficient magnetic retention leads to processor instability and frequent dislodgement during movement.

4. Active Transcutaneous Bone-Conduction Systems (e.g., Cochlear Osia, MED-EL Bonebridge)

• Surgical Mechanism: The active mechanical transducer is surgically implanted directly into or onto the temporal bone under an intact skin flap. The external processor contains the microphones, digital sound processor, and battery, transmitting digitized audio and power wirelessly across the intact skin via a transcutaneous radiofrequency (RF) inductive link.
  • Piezoelectric Transducer (Osia): Utilizes a Piezo Power piezoelectric actuator operating above its resonance frequency, providing exceptional high-frequency output and mechanical robustness.
  • Electromagnetic Transducer (Bonebridge): Employs an electromagnetic Floating Mass Transducer recessed into a surgically created mastoid well.
• Clinical Superiority: Active transcutaneous systems bridge the gap between percutaneous and passive transcutaneous devices. Because the implanted transducer is osseointegrated directly into the skull bone, vibration is delivered directly without skin dampening, while the intact skin barrier eliminates Holgers skin infections and pressure necrosis.

---

The Holgers Grading System for Soft-Tissue Reactions

Percutaneous abutment sites require standardized clinical assessment using the Holgers Grading Scale:

• Grade 0: Normal, healthy peri-abutment skin without signs of inflammation or redness. No clinical intervention required.
• Grade 1: Mild erythema and slight edema around the abutment. Managed with improved local hygiene, gentle crust removal, and topical petroleum or antiseptic ointment.
• Grade 2: Red and moist tissue but no granulation tissue. Managed with meticulous cleaning and topical antibiotic or antibiotic/corticosteroid preparations.
• Grade 3: Reddish, moist tissue with granulation tissue formation. Managed with local debridement, topical antibiotic/corticosteroid therapy, silver nitrate cautery of granulation tissue, and a pause in processor wear if needed; persistent cases may need surgical revision.
• Grade 4: Infection severe enough that the skin-penetrating abutment must be removed.

---

Active Middle Ear Implants (AMEI)

An Active Middle Ear Implant (AMEI), such as the MED-EL Vibrant Soundbridge (VSB), is an implantable hearing device designed to mechanically vibrate the middle ear ossicles or cochlear fluids directly.

Mechanism & Floating Mass Transducer (FMT)

• Electromechanical Architecture: The external audio processor captures acoustic sound, converts it into a digital radiofrequency signal, and transmits it transcutaneously to an internal receiver-stimulator. The receiver drives the Floating Mass Transducer (FMT)—a miniature titanium cylinder containing an internal permanent magnet suspended between two delicate silicone springs and wrapped in an electromagnetic coil.
• Vibrational Mechanics: Alternating electrical currents passing through the coil drive the internal magnet back and forth. By Newton's third law of motion, this creates equal and opposite mechanical reaction forces that vibrate the entire titanium FMT casing, delivering direct mechanical energy to the middle ear structure to which it is clamped.

Coupling Configurations (Vibroplasty)

1. Incus Long Process Vibroplasty: Standard application for moderate-to-severe sensorineural hearing loss. The FMT is clipped securely onto the long process of the incus, vibrating the ossicular chain in physiological phase with the oval window.
2. Stapes Vibroplasty: Used when the incus is necrotic or missing. The FMT is coupled directly to the stapes suprastructure or the stapes footplate.
3. Round Window Vibroplasty: Used in severe mixed or conductive losses with complete ossicular discontinuity or congenital ossicular aplasia. The FMT is positioned directly against the round window membrane (buffered by a fascia or perichondrium graft), directly mobilizing perilymph in the scala tympani.

Clinical Indications & Patient Selection

• Sensorineural Hearing Loss: Moderate-to-severe sensorineural hearing loss in adults who cannot tolerate conventional hearing aids due to chronic external otitis, recurring canal furunculosis, canal stenosis, severe eczema, or collapsing ear canals.
• Conductive and Mixed Hearing Loss: Stable bone-conduction thresholds with middle ear anatomy unsuitable for conventional tympanoplasty or ossiculoplasty.
• Audiological Advantages: Completely open ear canal eliminates occlusion effect, prevents canal moisture buildup, and eliminates acoustic feedback because there is no acoustic loudspeaker in the ear canal.

---

Audiometric Verification & Sound Field Testing

Because bone-conduction and active middle ear implants stimulate the auditory system mechanically rather than acoustically through an ear canal, traditional probe-microphone Real-Ear Measurements (REM) cannot be performed in the typical manner.

• In-Situ Bone-Conduction Thresholds (BC Direct): Modern BAHS processors measure behavioral bone-conduction thresholds directly through the osseointegrated transducer. This accounts for individual skull impedance, skin thickness (in transcutaneous systems), and fixture stability.
• Sound Field Functional Gain: Verified in a calibrated sound field under unaided versus aided conditions using frequency-modulated (warble) tones or narrow-band noise ($250-8000\,\text{Hz}$): $\text{Functional Gain (dB)} = \text{Unaided Sound Field Threshold (dB HL)} - \text{Aided Sound Field Threshold (dB HL)}$
• Speech-in-Noise Verification: Administered using standardized sentence materials (e.g., QuickSIN, BKB-SIN, AzBio) in various spatial configurations (speech front / noise front $S_0 N_0$, or speech front / noise impaired side $S_0 N_{\text{imp}}$) to quantify the reduction in head shadow and release from masking.